hero image

Biogen and Spin-off Bioverativ will Present at the Goldman Sachs Healthcare CEOs Unscripted Conference

December 21, 2016 News Release

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Goldman Sachs Healthcare CEOs Unscripted Conference. The webcast will be live on Thursday, January 5, 2017 at 4:00p.m. ET. Additionally, Bioverativ, the planned spin-off of Biogen’s hemophilia business, will present as well. That webcast will be live on Thursday, January 5, 2017 at 3:15p.m. ET.

To access the live webcasts, please visit Biogen’s Investors section at www.biogen.com/investors. An archived version of the webcast will be available for 14 days following the presentation.

The planned spin-off of Bioverativ is expected to be completed on February 1, 2017. Following the spin-off, Bioverativ will be an independent, publicly-held global biotechnology company dedicated to advancing the research, development and commercialization of innovative therapies to address areas of serious unmet need for people with hemophilia and other rare blood disorders.

About Biogen
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For more information, please visit www.biogen.com. Follow us on Twitter.

 

Contact:

Biogen
Karen Jewell, 781-464-2442
Investor Relations

$Cashtags

thumb
June 6, 2023
Biogen Withdrawal from the Jefferies Healthcare Conference

Cambridge, MA, - -  Biogen Inc. (Nasdaq: BIIB) announced today that it will not participate in the Jefferies Healthcare Conference on Wednesday, June 7, 2023. About Biogen Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations

thumb
June 1, 2023
Biogen Announces Webcast of Annual Meeting of Stockholders

Cambridge, Mass. – June 1, 2023 – Biogen Inc. (Nasdaq: BIIB) announced today that the webcast of the Company's 2023 Annual Meeting of Stockholders will be held on Wednesday, June 14, 2023, at 9:00 a.m. Eastern Time.  A live audio webcast of the meeting will be available on the Investor Relations